Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock

Benzinga and Yahoo finance LLC may earn commission or revenue on some elements through the links below.

Gilead Sciences Inc. (NASDAQ: GILD is an American pharmaceutical pharmaceutical company that is looking, developing and selling innovative drugs that threaten life, with a focus on HIV/AIDS, viral hepatitis, cancer, Covid-19, and inflammation.

Its profits will be reported in Q3 2025 on November 5. The Wall Street analysts expect that the company will publish the share profitability of $ 2.15, up from $ 2.02 in the previous year. According to Benzinga Pro data, quarterly revenues are expected to be $ 7.41 billion, a decrease of $ 7.54 billion in the previous year.

Do not miss:

The share range was 52 weeks of Gilead Sciences 78.36 dollars to 121.82 dollars.

Gilead Sciences is 2.73 %. It paid $ 3.16 per share in stock profits over the past 12 months.

The company announced on August 7 its profits in the second quarter of 2025, as the profitability of the modified arrow of $ 2.01 was published, compared to the estimation of the consensus amounting to $ 1.94, and revenues of $ 7.08 billion, compared to 8.94 billion dollars, as reported by Banzina.

“This was the very very successful quarter of Gilleid, including the approval of the FDA on Yaztogo as the first option to prevent HIV in the world,” said CEO. Daniel Odai. “Our strong growth in this quarter was driven by a bitarvie, Dikovi, Tudilphi and Lvilsey, which reflects the diversity of our wallet. With our entry into the third quarter, we increase the guidelines of revenues and profits for this year, and we look forward to providing continuous innovation and growth throughout the basic therapeutic areas.”

Over the course of 2025, the company expects that the EPS will be unacceptable from GAAP in the range of $ 7.95 to $ 8.25.

Trending: vacant rates less than 5 % and $ 2.3 billion in unparalleled demand – How can ordinary investors reach the American industrial boom?

If you want to get $ 100 per month – $ 1,200 annually – from Gilead Sciences distributions, your investment value should be about $ 43,956, which is about 379 shares at $ 115.88 each.

Understanding profit return accounts: When offering an estimate, you need two main variables – the required annual income ($ 1,200) and profit return (2.73 % in this case). Therefore, 1200 dollars / 0.0273 = 43,956 dollars to create an income of $ 100 a month.